» Articles » PMID: 18213635

Chromosome 8q24 Risk Variants in Hereditary and Non-hereditary Prostate Cancer Patients

Overview
Journal Prostate
Date 2008 Jan 24
PMID 18213635
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple variants in three regions at 8q24 are consistently found to be associated with prostate cancer (PCa) risk in population-based association studies. The role that these variants may play in familial prostate cancer risk has not been extensively investigated.

Methods: We evaluated 12 SNPs at three 8q24 regions using population-based association and family-based linkage and association methods in hereditary PCa (HPC) probands and their families, non-HPC patients, and unaffected screened controls, all recruited at Johns Hopkins Hospital.

Results: For multiple variants in Region 1 (e.g., rs1447295) and Region 2 (e.g., rs16901979), we found statistically significantly higher frequencies of previously identified risk alleles and genotypes in HPC probands than in unaffected controls. Furthermore, in Region 2 the risk alleles were statistically significantly more frequent in HPC probands than in non-HPC patients. Family-based transmission tests found risk alleles of SNPs in Region 2, but not in Regions 1 and 3, were significantly over-transmitted to affected men in these families. We found little evidence supporting PCa linkage at 8q24 in 168 HPC families, in part explained by the observation of multiple, different risk allele-containing haplotypes segregating in the vast majority of these families.

Conclusions: Our study further supports the presence of PCa susceptibility loci at 8q24, particular at Region 2, and also provides evidence that these SNPs play an important role in familial prostate cancer. Large family-based studies are needed to confirm our novel findings.

Citing Articles

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.

Jiang Y, Meyers T, Emeka A, Folgosa Cooley L, Cooper P, Lancki N HGG Adv. 2022; 3(1).

PMID: 34993496 PMC: 8725988. DOI: 10.1016/j.xhgg.2021.100070.


PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer.

Bardhan A, Banerjee A, Basu K, Pal D, Ghosh A Hum Genet. 2021; 141(1):15-29.

PMID: 34727260 PMC: 8561087. DOI: 10.1007/s00439-021-02396-8.


Cumulative evidence of relationships between multiple variants in 8q24 region and cancer incidence.

Tong Y, Tang Y, Li S, Zhao F, Ying J, Qu Y Medicine (Baltimore). 2020; 99(26):e20716.

PMID: 32590746 PMC: 7328976. DOI: 10.1097/MD.0000000000020716.


Cumulative Evidence for Relationships Between 8q24 Variants and Prostate Cancer.

Tong Y, Yu T, Li S, Zhao F, Ying J, Qu Y Front Physiol. 2018; 9:915.

PMID: 30061842 PMC: 6055007. DOI: 10.3389/fphys.2018.00915.


Multigene panels in prostate cancer risk assessment: a systematic review.

Little J, Wilson B, Carter R, Walker K, Santaguida P, Tomiak E Genet Med. 2015; 18(6):535-44.

PMID: 26426883 DOI: 10.1038/gim.2015.125.